Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemia Type II

Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.

176 public trials 32 recruiting studies

Hyperlipoproteinemia Type II trial results

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Pfizer Investigational Site Boston, Massachusetts, United States
  • Pfizer Investigational Site Chicoutimi, Quebec, Canada
  • Pfizer Investigational Site Ste-Foy, Quebec, Canada
  • Pfizer Investigational Site Parktown, Johannesburg, South Africa
Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Washington D.C., District of Columbia, United States
  • Pfizer Investigational Site Lutz, Florida, United States
  • Pfizer Investigational Site Tampa, Florida, United States
View all 41 locations
Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolaemia, +12 more
Locations
  • Novartis Investigative Site Handa, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Komaki, Aichi-ken, Japan
View all 107 locations
Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations
  • Hcor São Paulo, Brazil
  • OCARA Belém, Brazil
  • Centro Oncológico de Roraima Boa Vista, Brazil
  • Instituto de Cardiologia e Transplantes do DF Brasília, Brazil
View all 24 locations